PPT-Abuse-Deterrent Opioids:
Author : celsa-spraggs | Published Date : 2018-11-10
FDAs Role and Emerging Challenges Jeanne Ireland Principal Ireland Strategies LLC 2015 CWAG Annual Meeting The Opioid Epidemic Some progress being made but devastating
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Abuse-Deterrent Opioids:" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Abuse-Deterrent Opioids:: Transcript
FDAs Role and Emerging Challenges Jeanne Ireland Principal Ireland Strategies LLC 2015 CWAG Annual Meeting The Opioid Epidemic Some progress being made but devastating effects of epidemic continue. Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics. Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the most effective pain relievers available.. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None. Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill. He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship. While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972. For this he receive the Meritorious Service Medal. He has practiced adult psychiatry in Grand Junction for 28 years. He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . a Law enforcement. perspective. Charlie Cichon. Executive Director. The National Association of Drug Diversion Investigators (NADDI). The National Association of Drug Diversion Investigators, or NADDI, is a non-profit membership organization that works to develop and implement solutions to the problem of prescription drug diversion. . Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Joshua P. Cohen, PhD. Massachusetts State House. February 5, 2018. 20% of non-cancer pain patients are prescribed an . opioid. , compared to <5% in other industrialized nations. U.S. has 4% of the world’s population, yet 30% of global . Bureau of Health Care Safety and Quality. Department of Public Health. July 14, 2016. Review of June 2. nd. meeting. Non-Opioid Pain Management List. . Draft Formulary Guidance. Next Steps. Slide . Bureau of Health Care Safety and Quality. Department of Public Health. December 15, 2016. Draft Formulary (105 CMR 720). Schedule. Amendments. Comments. Guidance. Interchangeable Abuse Deterrent Drug Products Evaluation. a Law enforcement. perspective. Charlie Cichon. Executive Director. The National Association of Drug Diversion Investigators (NADDI). The National Association of Drug Diversion Investigators, or NADDI, is a non-profit membership organization that works to develop and implement solutions to the problem of prescription drug diversion. . Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). Psycho-Education for Patients and Family Members. 12-. 1. The Importance of Total Abstinence. Abstinence from all substances that affect the brain—even alcohol—greatly increases the chances of a successful recovery.. Methamphetamines. By: Christy Hicks. Regional TEAP Specialist. Atlanta, Chicago and Dallas Regions. This course is intended to give an overview of the most commonly abused drugs by Job Corps students..
Download Document
Here is the link to download the presentation.
"Abuse-Deterrent Opioids:"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents